TERMINATION OF MIGRAINE HEADACHE BY A NEW ANTI-INFLAMMATORY VASOCONSTRICTOR AGENT.
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D001794:Blood Pressure; D001916:Brachial Artery; D002339:Carotid Arteries; D004358:Drug Therapy; D004878:Ergotamine; D006801:Humans; D007211:Indoles; D007213:Indomethacin; D007427:Intracranial Pressure; D008881:Migraine Disorders; D012171:Retinal Vessels; D014116:Toxicology; D014653:Vascular Headaches; D014662:Vasoconstrictor Agents
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D007211:Indoles; D014662:Vasoconstrictor Agents; D004878:Ergotamine; D007213:Indomethacin
ANALGESICS AND ANTIPYRETICS; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERIES; DRUG THERAPY; ERGOTAMINE; INDOLES; INDOMETHACIN; INTRACRANIAL PRESSURE; MIGRAINE; RETINAL VESSELS; TOXICOLOGIC REPORT; VASCULAR HEADACHE; VASOCONSTRICTOR AGENTS